Background <p><i>Citrobacter braakii</i> (<i>C. braakii</i>) is a gram-negative bacterium associated with hospital-acquired infections such as respiratory tract infections and bacteremia. There has been a gradual increase in the number of <i>C. braakii</i> infection cases in recent years. The antimicrobial resistance level o<i>f C. braakii</i> has been steadily increasing, and the coexistence of multiple resistance genes further complicates the selection of appropriate clinical antibiotic therapies.</p> Results <p>we reported a multidrug-resistant <i>C. braakii</i> W221 co-harboring <i>bla</i><sub>NDM−1</sub>, <i>bla</i><sub>IMP−4</sub>, and <i>bla</i><sub>OXA−181</sub> with four key resistance encoding plasmids (pW221-1, pW221-2, pW221-4 and pW221-5). The results of antimicrobial susceptibility testing indicated that W221 exhibited high-level resistance to aminoglycosides, carbapenems and ceftazidime-avibactam. Conjugation assays indicated that plasmid pW221-1, <i>bla</i><sub>NDM−1</sub>-carrying plasmid pW221-4 and <i>bla</i><sub>OXA−181</sub>-carrying plasmid pW221-5 were transferrable to <i>Escherichia coli</i> (<i>E</i>. <i>coli</i>). In addition, <i>bla</i><sub>NDM−1</sub>-carrying plasmid pW221-4 and <i>bla</i><sub>OXA−181</sub>-carrying plasmid pW221-5 also could transfer to <i>Klebsiella pneumoniae</i>. Notably, mobilizable plasmid pW221-1 not only carried multiple resistance elements (such as <i>sul1</i>, <i>qnrA1</i>, etc.) but also possessed virulence factors (<i>vipA</i>/<i>tssB</i>). We also found that <i>bla</i><sub>NDM−1</sub>, <i>rmtC</i> and <i>sul1</i> resistance genes and virulence factor <i>htpB</i> co-occurred on the same mobilizable plasmid pW221-4. Detailed genetic analysis showed that multiple transposons (Tns) and insertion sequences (ISs) were found surrounding the vital resistant genes, which could stimulate mobilization of resistant determinants. <i>bla</i><sub>IMP−4</sub> was located on the class 1 integron In<i>823</i>. In addition, the <i>fosA3</i>-<i>bla</i><sub>SHV−12</sub>-<i>sul2</i>-<i>aph(3’’)-Ib</i>-<i>aph(6)-Id</i> -<i>qnrS1</i> antibiotic resistance island (ARI) in pW221-2 was surrounded by Tn<i>3</i>, IS<i>26</i>, IS<i>5075</i>, IS<i>Kpn</i>19, and Tn<i>5403</i>. Moreover, <i>bla</i><sub>NDM−1</sub>-carrying plasmid pW221-4 was typed as IncFII plasmid, which was known to have high-efficiency transmissibility. The <i>bla</i><sub>OXA−181</sub> gene was characterized by the following structure: IS<i>26</i>-IS<i>Ec63</i>-IS<i>3000</i>-<i>bla</i><sub>OXA−181</sub>-IS<i>Kpn19</i>-IS<i>Mex22-qnrS1</i>-IS<i>As17</i>-IS<i>26</i>.</p> Conclusions <p>we isolated a <i>C. braakii</i> W221 co-existing <i>bla</i><sub>NDM−1</sub>, <i>bla</i><sub>IMP−4</sub>, and <i>bla</i><sub>OXA−181</sub>, and this was first reported in the world. The presence of multiple transferrable and mobilizable plasmids carrying key resistance determinants suggested that this strain may have high potential for horizontal gene transfer and rapid dissemination. These findings suggesting that clinical settings should be vigilant against the further emergence, spread and prevalence of such novel multidrug-resistant strains.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Coexistence of blaNDM−1, blaIMP−4and blaOXA−181 in Citrobacter braakii clinical isolate in China

  • Shanshan Wang,
  • Jiao Zhang,
  • Bingjie Wang,
  • Ying Zhou,
  • Weihua Han,
  • Xiaocui Wu,
  • Yanlei Xu,
  • Fangyou Yu,
  • Huilin Zhao

摘要

Background

Citrobacter braakii (C. braakii) is a gram-negative bacterium associated with hospital-acquired infections such as respiratory tract infections and bacteremia. There has been a gradual increase in the number of C. braakii infection cases in recent years. The antimicrobial resistance level of C. braakii has been steadily increasing, and the coexistence of multiple resistance genes further complicates the selection of appropriate clinical antibiotic therapies.

Results

we reported a multidrug-resistant C. braakii W221 co-harboring blaNDM−1, blaIMP−4, and blaOXA−181 with four key resistance encoding plasmids (pW221-1, pW221-2, pW221-4 and pW221-5). The results of antimicrobial susceptibility testing indicated that W221 exhibited high-level resistance to aminoglycosides, carbapenems and ceftazidime-avibactam. Conjugation assays indicated that plasmid pW221-1, blaNDM−1-carrying plasmid pW221-4 and blaOXA−181-carrying plasmid pW221-5 were transferrable to Escherichia coli (E. coli). In addition, blaNDM−1-carrying plasmid pW221-4 and blaOXA−181-carrying plasmid pW221-5 also could transfer to Klebsiella pneumoniae. Notably, mobilizable plasmid pW221-1 not only carried multiple resistance elements (such as sul1, qnrA1, etc.) but also possessed virulence factors (vipA/tssB). We also found that blaNDM−1, rmtC and sul1 resistance genes and virulence factor htpB co-occurred on the same mobilizable plasmid pW221-4. Detailed genetic analysis showed that multiple transposons (Tns) and insertion sequences (ISs) were found surrounding the vital resistant genes, which could stimulate mobilization of resistant determinants. blaIMP−4 was located on the class 1 integron In823. In addition, the fosA3-blaSHV−12-sul2-aph(3’’)-Ib-aph(6)-Id -qnrS1 antibiotic resistance island (ARI) in pW221-2 was surrounded by Tn3, IS26, IS5075, ISKpn19, and Tn5403. Moreover, blaNDM−1-carrying plasmid pW221-4 was typed as IncFII plasmid, which was known to have high-efficiency transmissibility. The blaOXA−181 gene was characterized by the following structure: IS26-ISEc63-IS3000-blaOXA−181-ISKpn19-ISMex22-qnrS1-ISAs17-IS26.

Conclusions

we isolated a C. braakii W221 co-existing blaNDM−1, blaIMP−4, and blaOXA−181, and this was first reported in the world. The presence of multiple transferrable and mobilizable plasmids carrying key resistance determinants suggested that this strain may have high potential for horizontal gene transfer and rapid dissemination. These findings suggesting that clinical settings should be vigilant against the further emergence, spread and prevalence of such novel multidrug-resistant strains.